Susquehanna International Group, LLP Shattuck Labs, Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
Call Options
2 transactions
Others Institutions Holding STTK
# of Institutions
77Shares Held
31MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$7.44 Million2.25% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$6.2 Million0.55% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$5.24 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$2.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$2.69 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $47.5M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...